J. Reinmiedl

Morbidity and survival after bronchoplastic surgery for non-small-cell lung cancer.

C. Schinkel, C. Mueller, J. Reinmiedl, 2000, The Journal of cardiovascular surgery.

CEA, CYFRA 21-1, NSE, and ProGRP in the diagnosis of lung cancer: a multivariate approach / CEA, CYFRA 21-1, NSE und ProGRP in der Diagnostik des Lungenkarzinoms: eine multivariate Analyse

R. Hatz, P. Stieber, D. Nagel, 2008 .

Improved diagnosis of mesothelioma by a combination of soluble mesothelin-related peptide and CYFRA 21-1

R. Hatz, P. Stieber, S. Holdenrieder, 2015 .

Mediastinal lymph node infiltration in non-small cell lung cancer and its role in curative surgery.

H. Dienemann, C. Schinkel, H. Hoffmann, 1999, Scandinavian cardiovascular journal : SCJ.

Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.

H. Dienemann, P. Stieber, A. Schalhorn, 1999, Anticancer research.

Healthcare-associated exposure to Borna disease virus 1 (BoDV-1)

J. Rissland, D. Tappe, V. Ruf, 2022, Journal of Occupational Medicine and Toxicology.

Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer

Petra Stieber, Donna Ankerst, D. Ankerst, 2008, Tumor Biology.

Outcome following lung resections for pT1 non-small cell lung cancer.

H. Dienemann, R. Weidenhagen, I. Bittmann, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC).

H. Dienemann, P. Stieber, H. Hoffmann, 1999, Anticancer research.